AFP and neoplasm: Due to its association with adverse clinical features, like vascular invasion (e.g., portal vein thrombosis), high tumor proliferation, and a poor prognosis, it is used in combination with other biomarkers, such as AFP and AFP-L3, to enhance diagnostic accuracy [25,26,27].